News

The Manila Times4d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...
Morningstar4d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
AVT06/AVT29 is a recombinant fusion protein and a biosimilar candidate to Eylea® (aflibercept ... Please click here for full Prescribing Information for SELARSDI. Teva Pharmaceutical Industries ...
Le Lézard4d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDItm (ustekinumab-aekn) with Stelara® (ustekinumab)
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , and Alvotech today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDItm (ustekinumab-aekn) ...
Nasdaq4d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
About AVT06AVT06/AVT29 is a recombinant fusion protein and a biosimilar candidate to Eylea® (aflibercept ... Please click here for full Prescribing Information for SELARSDI.
Kauppalehti4d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
The U.S. FDA has approved SELARSDI ™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara ® (ustekinumab) in all presentations matching the reference product, effective as of ...
Yahoo Finance4d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
PARSIPPANY, N.J. & REYKJAVÍK, Iceland, May 05, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE ...